XML 38 R25.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders Equity and StockBased Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Stockholders Equity and StockBased Compensation  
Schedule Of stock option

 

 

Number of Options

 

 

Weighted Average Exercise Price

 

 

Weighted-

Average

Remaining

Contractual

Term (Years)

 

 

Aggregate

Intrinsic

Value

 

Outstanding, December 31, 2023

 

 

510,787

 

 

$17.88

 

 

 

3.84

 

 

$

 

Granted

 

 

71,330

 

 

 

2.91

 

 

 

 

 

 

 

 

Exercised

 

 

(10,974 )

 

 

3.82

 

 

 

 

 

 

 

60,102

 

Forfeited

 

 

(71,448 )

 

 

21.89

 

 

 

 

 

 

 

 

Expired

 

 

(34,755 )

 

 

5.33

 

 

 

 

 

 

 

 

Outstanding, December 31, 2024

 

 

464,940

 

 

$16.24

 

 

 

3.07

 

 

$184,818

 

Vested and expected to vest, December 31, 2024

 

 

464,940

 

 

$16.24

 

 

 

3.07

 

 

$184,818

 

Options exercisable, December 31, 2024

 

 

445,275

 

 

$16.81

 

 

 

2.80

 

 

$153,803

 

Schedule Of Share-based Compensation, Stock Options, Activity

 

 

Year Ended

 

 

 

December 31,

 

 

 

2024

 

 

2023

 

Expected volatility

 

75.36%-92.89%

 

 

68.13%-95.70%

 

Risk free interest rate

 

3.76%-4.54%

 

 

4.21%-5.12%

 

Dividend yield rate

 

 

 

 

 

 

Expected life

 

2 - 6 years

 

 

1 - 6 years

 

Closing price per share - common stock

 

$2.49 - $2.62

 

 

$4.31 - $4.35

 

Schedule Of outstanding RSU

 

 

Number of

Shares

 

 

Weighted-

Average

Grant Date

Fair Value

 

 

Aggregate

Intrinsic

Value

 

Outstanding, December 31, 2023

 

 

557,688

 

 

$4.95

 

 

$1,790,178

 

Awards granted

 

 

484,269

 

 

 

5.82

 

 

 

2,818,446

 

Awards vested

 

 

(253,425 )

 

 

5.72

 

 

 

1,430,838

 

Awards forfeited

 

 

(6,668 )

 

 

10.69

 

 

 

82,083

 

Outstanding, December 31, 2024

 

 

781,864

 

 

 

5.19

 

 

 

3,698,217

 

Schedule of stock based compensation expense

 

 

Year Ended

 

 

 

December 31,

 

 

 

2024

 

 

2023

 

Research and development expenses

 

$0.3

 

 

$0.2

 

General and administrative expenses

 

 

1.7

 

 

 

1.1

 

Total stock-based compensation expense

 

$2.0

 

 

$1.3